Two Start-ups announce drug discovery collaboration
Confo Therapeutics and DyNAbind collaborate to Identify Novel GPCR-Modulating Compounds
03-Jul-2019 -
Confo Therapeutics andDyNAbind GmbH announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR).
The collaboration will combine ConfoBody™-enabled GPCRs with DyNAbind’s Dynamic DNA-encoded Library for the discovery of small molecule GPCR-modulating compounds. Under ...
drug discovery
G protein-coupled receptors